Medical AI Firm OpenEvidence Secures $200M Funding Amid Industry Scrutiny of AI Claims
Medical AI startup OpenEvidence has reportedly secured $200 million in new funding, doubling its valuation to $6 billion. The funding announcement comes amid growing industry scrutiny of AI capability claims, with experts questioning marketing assertions from major technology firms.
Medical AI Startup Valuation Soars
OpenEvidence, which develops an ad-supported AI chatbot for medical practitioners, has reportedly raised $200 million at a $6 billion valuation, according to recent funding reports. This represents a significant increase from the company’s $3.5 billion valuation following a $210 million round in July, sources indicate. The rapid valuation growth highlights continued investor enthusiasm for healthcare artificial intelligence solutions despite broader market challenges.